Regulatory Leader ** Join a highly tipped Check Point Inhibitor NME ** Work with the Best, learn from the Best! - NYC

Reference: TM040322A

Expiry Date: 25-05-2022

Categories Biotech, Regulatory Affairs

Salary: On Application

Job Type: Full Time

New York County
United States

Apply for position

Job Description

About This Opportunity

I am looking for someone whom is both self-propelling and loves the science of oncology, moreover you will want to work with the best and learn with the best. The role is graded at Director level!

This is obviously for one of the top 3 companies in Oncology drug development space and based in the PA / NJ / NYC area!

This is joining a team working for a Team Lead, who has profound knowledge of the Check Point Inhibitors and the Oncology Solid Tumor space - this individual is willing to coach and develop you in a fast forward environment, where you will be assigned to a very promising asset, a new generation of Check Point inhibitors, and a drug currently in Ph 2 with their potentially ground-braking readouts coming in Summer 2022.

You will join the molecule pre Ph 3, for EOP2 and EU Scientific Advice. The molecule could, if data reads out, cascade across many tumor types, with the organization developing 2 lead indication types, and potentially many more to follow (there is a 1B efficacy seeking study already running). You will be in the centre of this and directly benefit.

You will be someone who wants to learn, grow and have the type of workload which informs your knowledge and gives you the breadth of experience to develop your regulatory strategy skills.

This role is not for the feint hearted but someone who sees that effort, thinking and influencing breads merit and promotion.

If all goes well, this NME will be a prioritized asset, and you will be a GRL on this programme, with the backing of the Team Lead, and in a company which has the money and know-how to capitalise on promising data quickly, and effectively.


Your Background

My client in return is looking for an Associate Director who wants their first Director role, commits to the program and wants to see it through. You could right now have been working the US Regulatory framework, and want to expand into Global (in a company where you will have Regional Leads to support you).

They do ask you have some Check Point Inhibitor space or at least know the Solid Tumor space well.

You will know if you are the right person, because you will follow the latest science and developments in Solid Tumor, and be an enthusiast for Oncology drug development, you will have existing regulatory experience, in the US or internationally.


Package & Benefits

You will receive a high end stock award annually (USD 40-50K before extra multipliers), a performance bonus, and the company will buyout any losses you have. Salary is decent and if you can show previous track record, even more so. The client wants someone who can start quickly, and attend office regularly, as you will sit opposite the Team Lead and learn from them.


To Apply!

To apply for this role, please contact Theo Moore or Roland Schnapka, on US 908-348-6714 -  We are available 8-7pm EST  Monday to Friday and also on the weekend (until 1pm EST) alternatively, please send a CV with a cell number and ideal times for speaking to or and we will reply by return.

We provide a high level of service because we believe this matters. Our people place individuals at the Specialist, Expert, Regional and Global Head levels, so if you want some advice on when or how to make your next step, or to understand what that next step might look like, let’s collaborate and explore these ideas with each other. ADV Talent Partners only advertise around 30% of our active roles, so for us to really help you, please Register or call us. We provide permanent and contract roles in the following areas, across the USA, Europe and Asia Pacific. General switchboard number 908-348-6714.

GDPR & Data Protection: Your information is safeguarded for GDPR, and you will have the right to edit, amend or delete and ’’be forgotten’’ at any time after your initial registration.